hero-pink

News

Press releases

January 6, 2022

Ambagon Therapeutics Launches with $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline

Media Contact

Rhiannon Jeselonis
978-417-1946
rhiannon@tenbridgecommunications.com